A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum
暂无分享,去创建一个
J. Zell | S. Lipkin | R. Benya | E. Szabo | D. Rosenberg | D. Gillen | Wen‐Pin Chen | R. Carroll | T. Morgan | Zhiliang Huang | Rachel Gonzalez | F. Meyskens | Asmita Bhattacharya | C. Tucker | V. Wong | L. Rodriguez | Allen Mo | Jinah Chung | Myra Arcilla